MedTrace Logo

Effect of Using a Lower Limb Robotic Device for Patients With Chronic Stroke

NCT03104127 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-01-18

No results posted yet for this study

Summary

This study will investigate if a lower limb robotic device can be used in a community setting to increase the amount of physical activity that individuals undertake following stroke and consequently improve biomechanical, physiological and health outcomes, in patients with stroke.

Conditions

  • Gait, Hemiplegic
  • Quality of Life
  • Vascular Stiffness
  • Stroke

Interventions

DEVICE

Alter G Bionic Leg

Participants are randomized to a 10 week, community-based bionic leg programme. Participants must use the leg for a minimum of 1 hour per day and continue to have active physical therapy sessions.

OTHER

Normal therapy (physiotherapy)

Participants are randomized to a normal therapy (physiotherapy) only program. Participants are also advised to undertake 1 hour a day of physical activity and have active physical therapy (physiotherapy) sessions.

Sponsors & Collaborators

  • Hobbs Rehabilitation

    collaborator OTHER

  • AlterG

    collaborator UNKNOWN

  • University of Gloucestershire

    collaborator OTHER

  • University of Chester

    collaborator OTHER

  • University of Southampton

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    collaborator OTHER

  • University of Winchester

    lead OTHER

Principal Investigators

  • James Faulkner, PhD · University of Winchester

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-24
Primary Completion
2019-07-01
Completion
2019-07-01
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03104127 on ClinicalTrials.gov